Delsona Therapeutics
PrivateLast Round
Accelerator
Dec 14, 2023
Company Overview
Delsona Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was an Accelerator round in December 2023.
Delsona Therapeutics is a clinical-stage therapeutics company developing a drug delivery platform, called UltraNav, which uses focused ultrasound to non-invasively open the blood-brain barrier for treating life-threatening diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delsona Therapeutics Comparables
Compare Delsona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cordance Medical | 84% | |
| NaviFUS Corp. | 82% | |
| Ceretas | 82% |
For institutional investors. Book with your work email.
Delsona Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Delsona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westchester County Biosciences Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 14, 2023
Received funding from Westchester County Biosciences Accelerator.
For institutional investors. Book with your work email.
Delsona Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Delsona Therapeutics's valuation, stock price, and market status.
Is Delsona Therapeutics a public or private company?
Delsona Therapeutics is a private company.
What is the current stock price of Delsona Therapeutics?
Delsona Therapeutics is a private company, so its shares have no public market price. Caplight tracks Delsona Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Delsona Therapeutics worth (valuation)?
Valuation information for Delsona Therapeutics is not publicly available.
Can I buy Delsona Therapeutics stock?
Delsona Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Delsona Therapeutics's last funding round?
Delsona Therapeutics's most recent funding round was Accelerator on December 14, 2023.
Who are the main investors in Delsona Therapeutics?
Key investors in Delsona Therapeutics include Westchester County Biosciences Accelerator.
Will Delsona Therapeutics IPO soon?
No public IPO plans have been announced for Delsona Therapeutics.
How can I track Delsona Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Delsona Therapeutics's shares on secondary markets.